DrugPatentWatch Database Preview
SCANDONEST PLAIN Drug Profile
see a sample report or, see our see our flat-rate plans
Which patents cover Scandonest Plain, and when can generic versions of Scandonest Plain launch?
The generic ingredient in SCANDONEST PLAIN is mepivacaine hydrochloride. There are six drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the mepivacaine hydrochloride profile page.
Summary for SCANDONEST PLAIN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 12 |
| Bulk Api Vendors: | 76 |
| Patent Applications: | 537 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | SCANDONEST PLAIN at DailyMed |
Pharmacology for SCANDONEST PLAIN
| Ingredient-type | Amides |
| Drug Class | Amide Local Anesthetic |
| Physiological Effect | Local Anesthesia |
Medical Subject Heading (MeSH) Categories for SCANDONEST PLAIN
Synonyms for SCANDONEST PLAIN
| (+-)-1-Methyl-2',6'-pipecoloxylidide monohydrochloride |
| (+/-)-Mepivacaine hydrochloride, >=98% (HPLC) |
| (1-Methyl-DL-piperidine-2-carboxylic acid)-2,6-dimethylanilide hydrochloride |
| (1-methyl-dl-piperidine-2-carboxylicacid)-2,6-dimethylanilidehydrochloride |
| 1-methyl-2 inverted exclamation mark ,6 inverted exclamation mark -pipecoloxylididehydrochloride |
| 1-Methyl-2 inverted exclamation marka,6 inverted exclamation marka-pipecoloxylidine hydrochloride |
| 1-Methyl-2',6'-pipecoloxylidide hydrochloride |
| 1-Methyl-2',6'-pipecoloxylidide monohydrochloride |
| 1-Methyl-2',6'-pipecoloxylidine hydrochloride |
| 16452-56-5 |
| 1722-62-9 |
| 2-Piperidinecarboxamide, N-(2,6-dimethylphenyl)-1-methyl-, monohydrochloride |
| 2-Piperidinecarboxamide, N-(2,6-dimethylphenyl)-1-methyl-, monohydrochloride, (+-)- |
| 2',6'-Pipecoloxylidide, 1-methyl -, monohydrochloride |
| 38423-99-3 |
| 6 inverted exclamation mark -pipecoloxylidide,1-methyl-2monohydrochloride |
| 722M629 |
| 96-88-8 (Parent) |
| A811391 |
| AB0012058 |
| AC-2102 |
| AC1L24K2 |
| ACT02686 |
| AK-61115 |
| AKOS015889311 |
| AN-14290 |
| ANW-46921 |
| API0003297 |
| Arestocaine hydrochloride |
| AX8032267 |
| BC220537 |
| BG0250 |
| BR-61115 |
| C-17796 |
| Carbocaina |
| Carbocaine (TN) |
| Carbocaine hydrochloride |
| Carbocaine monohydrochloride |
| carbocainehydrochloride |
| CAS-1722-62-9 |
| CC-30208 |
| CCG-101083 |
| CCG-39081 |
| CHEBI:6760 |
| CHEMBL1200440 |
| Chlorocain |
| CPD000058904 |
| CS-2729 |
| CTK8B4971 |
| D00738 |
| dl-1-methyl-2 inverted exclamation mark ,6 inverted exclamation mark -pipecoloxylididehydrochloride |
| dl-mepivacainehydrochloride |
| DSSTox_CID_11566 |
| DSSTox_GSID_31566 |
| DSSTox_RID_78885 |
| DTXSID4031566 |
| EINECS 217-023-9 |
| FT-0080089 |
| FT-0601566 |
| HE222297 |
| HMS1922D17 |
| HY-B0517A |
| I01-1865 |
| ISOCAINE HYDROCHLORIDE |
| KS-00001F7F |
| KS-1271 |
| LS-2120 |
| M2560 |
| MCULE-4459584385 |
| Meaverin |
| Mepicaton |
| Mepident |
| mepivacain hydrochloride |
| Mepivacaine (hydrochloride) |
| Mepivacaine chlorhydrate |
| Mepivacaine HCL |
| Mepivacaine hydrochloride |
| Mepivacaine hydrochloride (JP17/USP) |
| Mepivacaine hydrochloride [USAN:JAN] |
| Mepivacaine hydrochloride [USP:JAN] |
| Mepivacaine hydrochloride, 98.0-102.0%, meets USP testing specifications |
| Mepivacaine hydrochloride, European Pharmacopoeia (EP) Reference Standard |
| Mepivacaine hydrochloride, United States Pharmacopeia (USP) Reference Standard |
| Mepivacaine Monohydrochloride |
| Mepivacaine(hydrochloride) |
| MepivacaineHCL//Mepivacaine |
| Mepivastesin |
| Mepivicaine hydrochloride |
| MEPIVICAINE HYDROCHLORIDE (MEPIVICAINE (96-88-8)) |
| MFCD00144738 |
| MLS000028662 |
| MLS001074068 |
| MLS001424226 |
| MolPort-003-666-532 |
| N-(2,6-Dimethylphenyl)-1-methyl-2-piperidinecarboxamide hydrochloride |
| n-(2,6-dimethylphenyl)-1-methyl-2-piperidinecarboxamidmonohydrochloride |
| N-(2,6-dimethylphenyl)-1-methyl-piperidine-2-carboxamide hydrochloride |
| N-(2,6-dimethylphenyl)-1-methylpiperidine-2-carboxamide hydrochloride |
| N-(2,6-dimethylphenyl)-1-methylpiperidine-2-carboxamide hydrochloride (1:1) |
| N-(2,6-dimethylphenyl)-1-methylpiperidine-2-carboxamide;hydrochloride |
| N-(2,6-Dimethylphenyl)-1-methylpiperidine-2-carboxamidehydrochloride |
| N-(2,6-dimethylphenyl)(1-methyl(2-piperidyl))carboxamide, chloride |
| NC00333 |
| NCGC00095108-01 |
| NCGC00095108-02 |
| NCGC00095108-03 |
| NSC-758674 |
| NSC758674 |
| Opera_ID_1165 |
| Optocain |
| Pharmakon1600-01504148 |
| Polocaine (TN) |
| Q-201354 |
| RETIMRUQNCDCQB-UHFFFAOYSA-N |
| S-6505 |
| s3155 |
| Sabol |
| SAM001246875 |
| SBB057000 |
| SC-13935 |
| Scandinibsa |
| Scandonest |
| Scandonest plain (TN) |
| SCHEMBL34245 |
| SMR000058904 |
| SPECTRUM1504148 |
| ST2419639 |
| ST50993897 |
| TC-135666 |
| Tox21_111424 |
US Patents and Regulatory Information for SCANDONEST PLAIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Deproco | SCANDONEST PLAIN | mepivacaine hydrochloride | INJECTABLE;INJECTION | 088387-001 | Oct 10, 1984 | AP | RX | No | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | |||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
see a sample report or, see our see our flat-rate plans
see a sample report or, see our see our flat-rate plans
